Search the Newsreel

Akari Therapeutics, Plc (AKTX) stock price, news, quote and history

This article provides a comprehensive overview of Akari Therapeutics, Plc (AKTX) stock, including its real-time price, historical data, and key financial metrics. It highlights the company's focus on developing antibody-drug conjugates (ADCs) for cancer treatment, with lead products like AKTX-101 and AKTX-102. The report …

Akamai Workforce Protector (Formerly LayerX) Advances Enterprise Security

Akamai has launched Akamai Workforce Protector (formerly LayerX), a dedicated interaction security solution designed for the AI era. This new offering provides comprehensive visibility, AI usage control, secure enterprise browser capabilities, and real-time data loss prevention, integrating natively with Akamai’s global private access solution. …

Akamai Research: Nearly Half of Enterprise AI Use Bypasses Corporate Security, Creating Massive “Shadow AI” Visibility Gaps

Akamai Technologies, Inc. Key takeaways The rise of the "AI power user": Although AI has expanded across every business function, risk is heavily concentrated. A highly active group of power users are driving the vast majority of enterprise AI exposure. The dominance of "shadow …

Akamai tool can stop sensitive data from reaching unauthorized AI

Akamai (NASDAQ: AKAM) has launched Akamai Workforce Protector, formerly LayerX, a new security layer designed to prevent sensitive data from reaching unauthorized AI models and to govern the use of AI, SaaS, web, and private applications. This tool offers real-time AI governance, secure enterprise …

a.k.a. Brands (AKA) Reports Q2 Loss, Lags Revenue Estimates

Sakar Healthcare Ltd (NSE:SAKAR) (Q1 2027) Earnings Call Highlights: Oncology Momentum Drives ...

Akari Therapeutics CEO highlights WhiteHawk dual-payload ADC strategy

Akari Therapeutics announced a research collaboration with WhiteHawk Therapeutics to evaluate a dual-payload Antibody Drug Conjugate (ADC) strategy, combining Akari's PH1 spliceosome-modulating payload with WhiteHawk's TOP1 inhibitor. CEO Abizer Gaslightwala emphasized this partnership could accelerate innovation and broaden therapeutic activity in oncology. Akari also …

Exploring Analyst Estimates for Akamai Technologies (AKAM) Q2 Earnings, Beyond Revenue and EPS

Analysts expect Akamai Technologies (AKAM) to report a Q2 EPS of $1.58, an 8.7% year-over-year decline, on revenues of $1.09 billion, up 4.6%. The consensus EPS estimate has been revised down by 0.1% recently. Beyond headline figures, analysts project specific segment revenues, including $597.67 …

Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation

Akari Therapeutics has released a new CEO Corner segment featuring CEO Abizer Gaslightwala, discussing the strategic research collaboration with WhiteHawk Therapeutics. This collaboration aims to combine Akari's PH1 spliceosome-modulating payload with WhiteHawk's TOP1 inhibitor ADC platform to explore a novel dual-payload strategy, which Akari …

Quantinno Capital Management LP Lowers Stock Position in Akamai Technologies, Inc. $AKAM

Quantinno Capital Management LP reduced its stake in Akamai Technologies (NASDAQ:AKAM) by 11.4% in the first quarter, selling 13,798 shares and holding 107,475 shares valued at $12.34 million. Other institutional investors also adjusted their positions, and corporate insiders recently sold shares. The company has …

The Karnataka Bank Share Price Outlook: Where It Could Be in 3 Years

Akamai (AKAM) Q2 Earnings: What To Expect

Lesaka grants 1,000,000 stock options to Executive Chairman Ali Mazanderani

Lesaka Technologies Inc. (LSAK) has granted its Executive Chairman, Ali Mazanderani, a 1,000,000-share stock option award. The options have an exercise price of $5.00, vest on April 1, 2028, and become exercisable after April 1, 2029, expiring on April 1, 2030. This compensation award …

Mutakamela Insurance Swings to H1 Loss; Insurance Revenue Falls

BofA refuses to embrace cybersecurity darling ahead of earnings

Every investor has felt the itch to buy the one stock everyone else already owns. Fastly's chart this year has that kind of pull, a steady climb that turns skeptics into buyers with each new high. One of Wall Street's largest banks looked at …

Precision Trading with A.k.a. Brands Holding Corp. (AKA) Risk Zones

This article provides a precision trading analysis for A.k.a. Brands Holding Corp. (AKA), highlighting a potential shift in positive near-term sentiment and a broader weak alignment. It details a mid-channel oscillation pattern and identifies an exceptional 48.0:1 risk-reward short setup. The analysis includes institutional …

LESAKA TECHNOLOGIES INC. – Results of Lesaka August 3, 2026 Special Meeting of Shareholders

Lesaka Technologies shareholders approved Ali Mazanderani stock option grant at special meeting

Lesaka Technologies shareholders have approved a stock option grant for Executive Chairman Ali Mazanderani during a special meeting held on August 3, 2026. The grant authorizes 1,000,000 options to acquire common stock at an exercise price of USD 5 per share, with vesting set …

Indocement Tunggal Prakarsa (INTP) Cetak Kinerja Moncer di Semester I-2026

Sakar Healthcare eyes ₹200 crore oncology revenue in FY27

California State Teachers Retirement System Has $19.28 Million Stock Position in Akamai Technologies, Inc. $AKAM

The California State Teachers Retirement System increased its stake in Akamai Technologies, Inc. by 23.9% in the first quarter, now holding 167,857 shares valued at $19.28 million. Institutional investors collectively own 94.28% of the company. Akamai Technologies received a "Hold" consensus rating from analysts, …

Akamai (AKAM) Joins Tenzai To Bring Instant Vulnerability Mitigation To The Edge

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Tenzai has integrated its autonomous AI hacker platform with Akamai Technologies' Web Application Firewall for immediate vulnerability mitigation. The integration connects Tenzai's automated threat detection with Akamai's …

Is Akamai Technologies (AKAM) Undervalued After Its Run Up Ahead Of Earnings?

Akamai Technologies (AKAM) is approaching its August 6 earnings report with mixed signals for investors. While its stock has seen significant gains over the past year and analysts project it as 28% undervalued with a fair value of $159.30, its current P/E ratio is …

Gabelli Funds LLC Has $230,000 Stock Holdings in Akamai Technologies, Inc. $AKAM

Gabelli Funds LLC significantly reduced its stake in Akamai Technologies, Inc. by 99.9% in the first quarter, now holding 2,000 shares valued at $230,000. Despite this, institutional investors collectively own 94.28% of the company. Analysts have a "Hold" consensus rating with an average price …

Akamai Technologies, Inc. Revenue Breakdown – BIVA:AKAM

Akamai Technologies, Inc. (BIVA:AKAM) generated 75.86 billion MXN in revenue last year. The Security segment was the top performer, contributing 40.44 billion MXN, while the United States was the largest regional contributor with 38.56 billion MXN. This data highlights the company's key revenue streams …

Lesaka Technologies, Inc. Revenue Breakdown – NASDAQ:LSAK

Lesaka Technologies, Inc. (NASDAQ: LSAK) generated $328.70 million USD in revenue last year. The company's top-performing segment was Merchant, which contributed $524.25 million USD, an increase from $495.01 million USD in the previous year. Geographically, South Africa was the largest contributor to revenue, accounting …

Price to earnings forward of Akari Therapeutics Plc – NASDAQ:AKTX

The article focuses on the "Price to earnings forward" metric for Akari Therapeutics Plc (NASDAQ: AKTX). It presents a financial data point for the company, indicating the period and value of this specific financial ratio. The content primarily appears to be a data display …

Aakash Exploration promoter acquires 7.19% stake via gift

Akari Therapeutics Plc Revenue Breakdown – NASDAQ:AKTX

This article provides a brief overview of Akari Therapeutics Plc (NASDAQ: AKTX) financials, specifically focusing on its revenue breakdown. It indicates that further detailed financial information, including segments and regional performance, is available through TradingView and its data partners like ICE Data Services and …

Lesaka Technologies Inc (LSAK) Valuation: PE, PB & Fair Value Analysis

Lesaka Technologies Inc (LSAK) currently holds a valuation score of 9.09, placing it 10th out of 76 companies in the Financial Technology (Fintech) & Infrastructure industry. Its P/E ratio stands at -14.36, which is notably lower than its recent high but above its recent …

Lesaka Technologies Inc (LSAK) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Lesaka Technologies Inc (LSAK), highlighting its current risk score of 3.71, ranking 28th in the Financial Technology (Fintech) & Infrastructure industry. The company's beta of 0.36 suggests it tends to underperform in rising markets but experiences smaller …

AKA Brands Holding Corp (AKA) Institutional Confidence

AKA Brands Holding Corp (AKA) has an institutional shareholding score of 5.00, placing it 62nd out of 93 in the Specialty Retailers industry. The institutional shareholding proportion is 56.74%, showing a slight decrease of 0.80% quarter-over-quarter. James Simons is identified as the largest institutional …

Philippos Nakas S.A. Revenue Breakdown – ATHEX:NAKAS

Lesaka Technologies Inc (LSAK) Financial Health: Profitability & Balance Sheet Analysis

Lesaka Technologies Inc (LSAK) currently holds a robust financial score of 9.09, ranking 7th within the Financial Technology (Fintech) & Infrastructure industry. The company demonstrated strong operating efficiency with a 34.92% year-over-year increase in quarterly revenue, reaching $183.05 million, and a 102.52% year-over-year increase …

Lesaka Executive Chairman Mazanderani pay set at USD 600,000 base salary under extended contract

Lesaka Technologies has amended the employment agreement for its Executive Chairman, Ali Mazanderani, extending his term until June 30, 2029. Under the new terms, Mazanderani will receive an annual base salary of USD 600,000, with a commitment fixed at 50% full-time equivalent. The agreement …

Lesaka Technologies (LSAK) sees Apis Growth report 2.1% ownership stake in 13G/A

Apis Growth 13 Limited, along with its directors Mr. Sattish Lalljee and Mr. Xie Fei Pang Wong Lin, has reported an amended ownership stake of 2.1% in Lesaka Technologies, Inc. (LSAK). This represents 1,719,368 shares of common stock out of 85,736,223 shares outstanding as …